Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11216866rdf:typepubmed:Citationlld:pubmed
pubmed-article:11216866lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C1704223lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0015684lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0005330lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0050690lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0428631lld:lifeskim
pubmed-article:11216866lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11216866pubmed:issue1-2lld:pubmed
pubmed-article:11216866pubmed:dateCreated2001-2-16lld:pubmed
pubmed-article:11216866pubmed:abstractTextRats treated with bezafibrate, a PPAR activator, gain less body weight and increase daily food intake. Previously, we have related these changes to a shift of thermogenesis from brown adipose tissue to white adipose tissue attributable to bezafibrate, which induces uncoupling proteins (UCP), UCP-1 and UCP-3, in rat white adipocytes. Nevertheless, UCP induction was weak, implying additional mechanisms in the change of energy homeostasis produced by bezafibrate. Here we show that bezafibrate, in addition to inducing UCPs, modifies energy homeostasis by directly inducing aco gene expression and peroxisomal fatty acid beta-oxidation in white adipose tissue. Further, bezafibrate significantly reduced plasma triglyceride and leptin concentrations, without modifying the levels of PPARgamma or ob gene in white adipose tissue. These results indicate that bezafibrate reduces the amount of fatty acids available for triglyceride synthesis in white adipose tissue.lld:pubmed
pubmed-article:11216866pubmed:languageenglld:pubmed
pubmed-article:11216866pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:citationSubsetIMlld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11216866pubmed:statusMEDLINElld:pubmed
pubmed-article:11216866pubmed:monthJanlld:pubmed
pubmed-article:11216866pubmed:issn0300-8177lld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:RodríguezCClld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:VázquezMMlld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:CabreraSSlld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:AdzetTTlld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:SánchezR MRMlld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:LagunaJ CJClld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:AlegretMMlld:pubmed
pubmed-article:11216866pubmed:authorpubmed-author:RoglansNNlld:pubmed
pubmed-article:11216866pubmed:issnTypePrintlld:pubmed
pubmed-article:11216866pubmed:volume216lld:pubmed
pubmed-article:11216866pubmed:ownerNLMlld:pubmed
pubmed-article:11216866pubmed:authorsCompleteYlld:pubmed
pubmed-article:11216866pubmed:pagination71-8lld:pubmed
pubmed-article:11216866pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:meshHeadingpubmed-meshheading:11216866...lld:pubmed
pubmed-article:11216866pubmed:year2001lld:pubmed
pubmed-article:11216866pubmed:articleTitleBezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue.lld:pubmed
pubmed-article:11216866pubmed:affiliationDepartamento Farmacología y Química Terapéutica, Facultad de Farmacia, Núcleo Universitario de Pedralbes, Barcelona, Spain.lld:pubmed
pubmed-article:11216866pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11216866pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11216866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11216866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11216866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11216866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11216866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11216866lld:pubmed